Phaseline

Targets › CD362

CD362: drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 1; Infectious disease.

Open in Phaseline: the race on CD362, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Belfast Health and Social Care TrustHuman umbilical cord derived CD362 enriched MSCs
Mesenchymal stem cell therapy with CD362 enrichment
CD362Phase 1Acute Respiratory Distress Syndrome–

Conditions

Acute Respiratory Distress Syndrome (1)

Modalities

protein or peptide (1)

Companies

Belfast Health and Social Care Trust (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.